BC-12-VG35_10uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=10uM, N-{3-[6-(3,6-Dihydro-2H-pyran-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-5-fluoro-2-methyl-phenyl}-2-fluoro-4-(1-hydroxy-1-methyl-ethyl)-benzamide, reversible BTK inhibitor targeting BTK (Novartis, 71230655)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/71230655
Similar Terms
Downloads & Tools

Genes

12 genes differentially expressed following the BC-12-VG35_10uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
MBD3L2 methyl-CpG binding domain protein 3-like 2 0.623411
MBD3L2B methyl-CpG binding domain protein 3 like 2B 0.380737
MBD3L5 methyl-CpG binding domain protein 3-like 5 0.245758
MBD3L3 methyl-CpG binding domain protein 3-like 3 0.240904

decreased expression

Symbol Name Standardized Value
DENND1A DENN/MADD domain containing 1A -0.582475
TAGLN transgelin -0.532215
SEC61A1 Sec61 alpha 1 subunit (S. cerevisiae) -0.3335
SRMS src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites -0.3335
CRYBG2 crystallin beta-gamma domain containing 2 -0.3335
MYL9 myosin, light chain 9, regulatory -0.240904
CTXN1 cortexin 1 -0.21296
UBE2S ubiquitin-conjugating enzyme E2S -0.20074